Radiologic Evaluation Criteria for Chronic Subdural Hematomas: Recommendations for Clinical Trials
Standard
Radiologic Evaluation Criteria for Chronic Subdural Hematomas: Recommendations for Clinical Trials. / McDonough, R; Bechstein, M; Fiehler, J; Zanolini, U; Rai, H; Siddiqui, A; Shotar, E; Rouchaud, A; Kallmes, K; Goyal, M; Gellissen, S.
in: AM J NEURORADIOL, Jahrgang 43, Nr. 11, 11.2022, S. 1550-1558.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Radiologic Evaluation Criteria for Chronic Subdural Hematomas: Recommendations for Clinical Trials
AU - McDonough, R
AU - Bechstein, M
AU - Fiehler, J
AU - Zanolini, U
AU - Rai, H
AU - Siddiqui, A
AU - Shotar, E
AU - Rouchaud, A
AU - Kallmes, K
AU - Goyal, M
AU - Gellissen, S
N1 - © 2022 by American Journal of Neuroradiology.
PY - 2022/11
Y1 - 2022/11
N2 - Embolization of the middle meningeal artery has gained substantial interest as a therapy for chronic subdural hematomas. For the results of the currently running chronic subdural hematoma trials to inform clinical practice, sufficient accuracy and matching definitions are necessary. We summarized the current practice in chronic subdural hematoma evaluation and derived suggestions on reporting standards using the {Nested} Knowledge AutoLit living review platform. On the basis of the most commonly reported data elements, we suggested a set of standardized image-based study end points for chronic subdural hematoma evaluation for future trials. The measurement methods and reporting standards as proposed in this article have been derived from published best practices and are endorsed by the European Society of Minimally Invasive Neurological Therapy's research committee. The standardization of radiologic outcome measures and measurement techniques in chronic subdural hematoma embolization trials would increase the impact and implication of each trial as well as facilitate data pooling for increased statistical power and, therefore, translation to clinical practice.
AB - Embolization of the middle meningeal artery has gained substantial interest as a therapy for chronic subdural hematomas. For the results of the currently running chronic subdural hematoma trials to inform clinical practice, sufficient accuracy and matching definitions are necessary. We summarized the current practice in chronic subdural hematoma evaluation and derived suggestions on reporting standards using the {Nested} Knowledge AutoLit living review platform. On the basis of the most commonly reported data elements, we suggested a set of standardized image-based study end points for chronic subdural hematoma evaluation for future trials. The measurement methods and reporting standards as proposed in this article have been derived from published best practices and are endorsed by the European Society of Minimally Invasive Neurological Therapy's research committee. The standardization of radiologic outcome measures and measurement techniques in chronic subdural hematoma embolization trials would increase the impact and implication of each trial as well as facilitate data pooling for increased statistical power and, therefore, translation to clinical practice.
KW - Humans
KW - Hematoma, Subdural, Chronic/diagnostic imaging
KW - Meningeal Arteries
KW - Embolization, Therapeutic/methods
U2 - 10.3174/ajnr.A7503
DO - 10.3174/ajnr.A7503
M3 - SCORING: Review article
C2 - 35618427
VL - 43
SP - 1550
EP - 1558
JO - AM J NEURORADIOL
JF - AM J NEURORADIOL
SN - 0195-6108
IS - 11
ER -
